ASCELTA Trademark

Trademark Overview


On Monday, March 14, 2016, a trademark application was filed for ASCELTA with the United States Patent and Trademark Office. The USPTO has given the ASCELTA trademark a serial number of 86938978. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 7, 2023. This trademark is owned by GW Research Limited. The ASCELTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical *preparations * and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut * syndrome * (LGS), tubero...
ascelta

General Information


Serial Number86938978
Word MarkASCELTA
Filing DateMonday, March 14, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 7, 2023
Registration Number5108168
Registration DateTuesday, December 27, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2016

Trademark Statements


Amendment to a Registration/Renewal CertificateIn the statement, Line 14, "preparations" is inserted after "pharmaceutical" In the statement, Line 15, "syndrome" is inserted after "Lennox-Gastaut".
Goods and ServicesPharmaceutical preparations and substances for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical *preparations * and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut * syndrome * (LGS), tuberous sclerosis syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15q infantile spasms, and Doose syndrome; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, bone disorders, hypoxic-ischaemic encephalopathy, drug, alcohol and nicotine abuse and inflammatory disorders; pure extracts of medicinal plants and herbs used for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, hypoxic-ischaemic encephalopathy, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; herb teas for medicinal purposes
Translation of Words in MarkThe wording "ASCELTA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGW Research Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge CB249BZ
GB

Party NameGW Research Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge CB249BZ
GB

Party NameGW Research Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge CB249BZ
GB

Trademark Events


Event DateEvent Description
Friday, July 7, 2023CANCELLED SEC. 8 (6-YR)
Monday, December 27, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 28, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, November 29, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 13, 2017AMENDMENT UNDER SECTION 7 ¿ PROCESSED
Monday, June 12, 2017ASSIGNED TO PARALEGAL
Monday, March 20, 2017TEAS SECTION 7 REQUEST RECEIVED
Monday, March 20, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 27, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, October 11, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 11, 2016PUBLISHED FOR OPPOSITION
Wednesday, September 21, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 7, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 30, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 30, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 30, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 24, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 23, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 23, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 22, 2016ASSIGNED TO LIE
Monday, August 15, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 1, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 1, 2016NON-FINAL ACTION E-MAILED
Friday, July 1, 2016NON-FINAL ACTION WRITTEN
Friday, June 24, 2016ASSIGNED TO EXAMINER
Thursday, March 17, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 17, 2016NEW APPLICATION ENTERED